<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1390</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2011</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>25</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Long term effects of Gamma knife Radiosurgery for treatment of cerebral arteriovenous malformations</title>
	<subject_fa>Neurosurgery</subject_fa>
	<subject>Neurosurgery</subject>
	<content_type_fa>case report</content_type_fa>
	<content_type>case report</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt; &lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Background: &lt;/strong&gt;The Gamma Knife Radiosurgery (GKR) is an established management option for Cerebral Ar-teriovenous Malformations (AVMS). Therapeutic benefits of radiosurgery for arteriovenous malformations are complete obliteration of nidus with minimal neurological deficit.&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Methods:&lt;/strong&gt; Radiosurgery was performed between February 2003 and April 2010 at Kamraniye day clinic, Teh-ran, Iran, using the Leksell gamma knife model B (Elektra Instruments AB, Stockholm, Sweden) on 82 consecu-tive patients with AVMs. The male-to-female ratio was 1.4:1(48M, 34F). The age of the patients ranged from 9 to 70 years (mean, 28.5±12 years). The marginal dose to the AVM nidus was 45 to 85% (median, 60%) isodose and ranged from 14 to 30 Gy (mean, 20.57±13Gy).The maximum dose ranged between 20 to 60 Gy (mean, 37.5 Gy ± 10.17Gy ). Follow up of patients for complete AVM obliteration and in the case of complications MRI were performed.&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Results:&lt;/strong&gt; Complete obliteration of AVM was achieved in 56 cases (68.29%). It was marked in average 3.62 [SD=3.19] years (from 1 to 5 years) after GKR. Partial obliteration (≥50% reduction of the nidus volume) was marked in 24 cases(31%), and less than 50% reduction of the nidus volume was marked in 2 cases(2.4%) with a follow-up of 5 years. Complete obliteration of AVM had statistically significant associations with smaller score of Spetzler-Martin arteriovenous malformation grading system for AVMs. (p&lt; 0.05)&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Conclusion:&lt;/strong&gt; The Gamma Knife Radiosurgery can offer total and partial obliteration to acceptable percent of treated AVM with a low risk of morbidity. Higher success observed in patients with Spetzler-Martin Grade I and II AVMs, which was attributed to smaller volume of AVMs in this group.&lt;/p&gt;&lt;p&gt;  &lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Gamma Knife Radiosurgery (GKR), Arteriovenous malformations, Obliteration rate</keyword>
	<start_page>119</start_page>
	<end_page>126</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1-243&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Maziar</first_name>
	<middle_name></middle_name>
	<last_name> Azar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>maziarazar@yahoo.com</email>
	<code>20031947532846002622</code>
	<orcid>20031947532846002622</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Farid</first_name>
	<middle_name></middle_name>
	<last_name> Kazemi Gazik</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>faridkazemi@lide.com</email>
	<code>20031947532846002623</code>
	<orcid>20031947532846002623</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mahdi</first_name>
	<middle_name></middle_name>
	<last_name> Nikoobakht</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mnikobakht@gmail.com</email>
	<code>20031947532846002624</code>
	<orcid>20031947532846002624</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Tehran University of Medical Sciences, Tehran, Iran. Address: 4th floor,# 9, Snd Golbarg St., Kharazmi St., Mollasadra Ave.,Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohamad-Reza </first_name>
	<middle_name></middle_name>
	<last_name>Yousefi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>dr_yousefi1980@yahoo.com</email>
	<code>20031947532846002625</code>
	<orcid>20031947532846002625</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Yaser </first_name>
	<middle_name></middle_name>
	<last_name>Ghavami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ghavami.y@gmail.com</email>
	<code>20031947532846002626</code>
	<orcid>20031947532846002626</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
